Multiple Sclerosis

The NeurologyLive® MS Disease Spotlight page offers specific updates and coverage on the latest expert conversations and data readouts related to the treatment and management of patients with multiple sclerosis and demyelinating disorders.

Latest News

Helius’ PoNS Neurostimulation Device Advances Toward Stroke Indication Following Registrational Program Data
Helius’ PoNS Neurostimulation Device Advances Toward Stroke Indication Following Registrational Program Data

July 23rd 2025

Helius reported promising results for its Portable Neuromodulation Stimulator, enhancing gait and balance in poststroke patients, with FDA submission planned.

Collateral Damage to Patients From Formulary Restrictions in Multiple Sclerosis: Perspectives from an MS Specialist, a Patient, and a Neurologist in Training
Collateral Damage to Patients From Formulary Restrictions in Multiple Sclerosis: Perspectives from an MS Specialist, a Patient, and a Neurologist in Training

July 22nd 2025

30-Year Analysis Suggests Regression of Progressive Multiple Sclerosis, Attributed Partly to Advances in Therapeutics
30-Year Analysis Suggests Regression of Progressive Multiple Sclerosis, Attributed Partly to Advances in Therapeutics

July 12th 2025

Aetna Joins UnitedHealthcare and Anthem in Authorizing PoNS Device Claims for Patients With MS
Aetna Joins UnitedHealthcare and Anthem in Authorizing PoNS Device Claims for Patients With MS

June 18th 2025

NeuroVoices: Tiffany Malone, MSW, MSCS, on Combating Loneliness in MS Care Through Connection and Community Programs
NeuroVoices: Tiffany Malone, MSW, MSCS, on Combating Loneliness in MS Care Through Connection and Community Programs

June 18th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.